These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31232717)

  • 1. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what's new?
    Lam SC; Yuen HKL
    Curr Opin Ophthalmol; 2019 Sep; 30(5):380-385. PubMed ID: 31232717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sclerotization of orbital lymphangioma with OK-432].
    Lagrèze W; Metzger M; Rössler J
    Ophthalmologe; 2014 May; 111(5):479-81. PubMed ID: 24706253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy of lymphangiomas of the head and neck.
    Wiegand S; Eivazi B; Zimmermann AP; Sesterhenn AM; Werner JA
    Head Neck; 2011 Nov; 33(11):1649-55. PubMed ID: 20737487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
    Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital lymphangioma.
    Pitz S; Dittrich M
    Br J Ophthalmol; 2000 Jan; 84(1):124-5. PubMed ID: 10611113
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of lymphatic malformations in children.
    Bagrodia N; Defnet AM; Kandel JJ
    Curr Opin Pediatr; 2015 Jun; 27(3):356-63. PubMed ID: 25888145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review.
    Patel KC; Kalantzis G; El-Hindy N; Chang BY
    In Vivo; 2017; 31(2):263-266. PubMed ID: 28358710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on orbital lymphatic malformations.
    Lally SE
    Curr Opin Ophthalmol; 2016 Sep; 27(5):413-5. PubMed ID: 27219273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
    Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment options for lymphangioma in infants and children.
    Giguère CM; Bauman NM; Smith RJ
    Ann Otol Rhinol Laryngol; 2002 Dec; 111(12 Pt 1):1066-75. PubMed ID: 12498366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment of slow-flow vascular malformations.
    Burrows PE
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):12-21. PubMed ID: 23499128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unsuccessful treatment with OK-432 picibanil for orbital lymphangioma].
    Lanuza García A; Bañón Navarro R; Llorca Cardeñosa A; Delgado Navarro C
    Arch Soc Esp Oftalmol; 2012 Jan; 87(1):17-9. PubMed ID: 22248653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
    Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
    J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
    Yoo JC; Ahn Y; Lim YS; Hah JH; Kwon TK; Sung MW; Kim KH
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):120-3. PubMed ID: 19130974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Sclerotherapy With OK-432 of a Cervicomediastinal Lymphangioma.
    Golinelli G; Toso A; Borello G; Aluffi P; Pia F
    Ann Thorac Surg; 2015 Nov; 100(5):1879-81. PubMed ID: 26522530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
    Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
    Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CYSTIC LYMPHATIC MALFORMATIONS IN CHILDREN: CLINICAL SIGNS AND CHOICE OF THE TREATMENT TACTIC].
    Benzar IM
    Klin Khir; 2016; (12):37-9. PubMed ID: 30272867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to OK-432 sclerotherapy in the treatment of cervical lymphangioma with submucosal extension to the airway.
    Manzini M; Schweiger C; Manica D; Kuhl G
    Braz J Otorhinolaryngol; 2020; 86(1):127-129. PubMed ID: 27297957
    [No Abstract]   [Full Text] [Related]  

  • 20. Sclerosing of recurrent lymphangioma using OK-432.
    Mikhail M; Kennedy R; Cramer B; Smith T
    J Pediatr Surg; 1995 Aug; 30(8):1159-60. PubMed ID: 7472972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.